Answer
The safety and efficacy of Korserdu (elacestrant dihydrochloride) have not been established in children from birth to 18 years of age, and no data are available.
Sources for this answer
- Korserdu (elacestrant) 345mg film-coated tabletsMenarini Stemline UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated
Sources checked